A Phase 1 TP-271 Oral PK Single Ascending Dose Study

Clinical trial NCT03024034 · COMPLETED

Trial details

NCT number: NCT03024034
Sponsor: Tetraphase Pharmaceuticals, Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bacterial Infections

Start date: 2017-03-02
Primary completion: 2017-12-01
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.